---
title: The tyrosine kinase Yes1 is a druggable host factor of HEV
date: '2024-11-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39560373/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241119173556&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: We identified the dependence of HEV on Yes1 signaling,
  which may contribute to the so far scarce knowledge of HEV''s pathogenesis in the
  future. Moreover, we provide Y1KI as a novel antiviral drug candidate specifically
  targeting an HEV host ...'
disable_comments: true
---
CONCLUSIONS: We identified the dependence of HEV on Yes1 signaling, which may contribute to the so far scarce knowledge of HEV's pathogenesis in the future. Moreover, we provide Y1KI as a novel antiviral drug candidate specifically targeting an HEV host ...